Common Surgical Procedures Gyn/Oncology 1

Total Page:16

File Type:pdf, Size:1020Kb

Common Surgical Procedures Gyn/Oncology 1 Common Surgical Procedures Gyn/Oncology Malignancy Description Codes wRVU Comments Cervical Typical Open Cone biopsy 57520 4.11 Leep conization 57522 3.67 Colposcopy/Leep 57461 3.43 TAH +/ - BSO 58150 17.31 Radical hysterectomy 58210 30.91 Includes excision of parametria and +/- BSO ureteral dissection. Pelvic lymphadenectomy (Total, bilateral) Can be used for TAH PLND Para-aortic sampling Radical trachelectomy 57531 29.95 +/-BSO Pelvic lymphadenectomy (Total bilateral) Para-aortic sampling Cervical Less Common Open Radical vaginal hyst (Schauta) 58285 23.38 Includes excision of parametria and ureteral dissection Modifier 52 fertility sparing +/- nodes Radical vaginectomy 57107 24.56 Includes removal of paravaginal tissue Partial removal wall Partial Vaginectomy use 57106 Radical vaginectomy 57109 28.40 Includes removal of paravaginal tissue Partial removal wall Pelvic lymphadenectomy (Total bilateral) Para-aortic sampling Radical vaginectomy 57111 28.40 Includes removal of paravaginal t issue Complete removal wall Complete vaginectomy 57110 Radical vaginectomy 57112 30.52 Includes removal of paravaginal tissue Complete removal wall Pelvic lymphadenectomy (Total bilateral) Para-aortic sampling Pelvic lymphadenectomy 387 70 14.06 Use modifier 50 for bilateral procedure External iliac Hypogastric/Obturator Cervical Laparoscopic Radical hysterectomy 58548 31.63 +/- BSO Pelvic lymphadenectomy (Total bilateral) Para-aortic sampling Pelvic lymphadenectomy 38571 14.76 (Total bilateral) Pelvic lymphaden ectomy 38572 16.94 (Total bilateral) Para-aortic sampling 1 Common Surgical Procedures Gyn/Oncology Malignancy Description Codes wR VU Comments Endometrial Open TAH +/ - BSO 58150 17.31 TAH +/ - BSO 58200 23.10 P&P sampling Radical hysterectomy 58210 30.91 Includes excision of parametria and +/- BSO ureteral dissection. Pelvic lymphadenectomy Can be used for TAH PLND (Total, bilateral) Para-aortic sampling TAH/BSO 58953 34.13 Omentectomy Debulking TAH/BSO 58954 37.13 Omentectomy Debulking Pelvic lymphadenectomy Limited para-aortic lymphadenectomy TAH/BSO 58956 22.80 Code indicates used for malignancy only Omentectomy TAH/BSO 58210 - 30.91 Increase fee to reflect use of modifier 22 P&P nodes 22 Omentectomy Endometrial Laparoscopic LAVH <250gms 58550 15.10 LAVH BSO 58552 16.91 LAVH >250gms 58553 20.06 LAVH BSO 58554 23.11 TLH <250gms 58570 15.88 TLH BSO 58571 17.69 TLH >250gms 58572 20.09 TLH BSO 58573 23.11 Endometrial Laparoscopic Nodes Retroperitoneal sampling 38570 9.34 Single or multiple node s Pelvic lymphadenectomy 38571 14.76 (Total bilateral) Pelvic lymphadenectomy 38572 16.94 Single or multiple nodes (Total bilateral) Para-aortic sampling 2 Common Surgical Procedures Gyn/Oncology Malignancy Description Codes wR VU Comments Ovarian/ Open Peritoneal Oophorectomy 58943 19.52 Partial or total oophorectomy, unilateral P&P node sampling or bilateral Peritoneal biopsies/washings Specific for ovarian, tubal, or primary +/- salpingectomy peritoneal malignancy +/- omentectomy BSO 58950 18.37 Initial resection of ov arian, tubal, or Omentectomy primary peritoneal malignancy TAH/BSO 58951 24.26 Initial resection of ovarian, tubal, or Omentectomy primary peritoneal malignancy Pelvic lymphadenectomy Limited para-aortic lymphadenectomy BSO 58952 27.29 Initial resection of ovarian, tubal, or Omentectomy primary peritoneal malignancy Debulking (radical dissection) Radical excision/destruction intra- abdominal or retroperitoneal tumors TAH/BSO, 58953 34.13 All sites Omentectomy Debulking (radical dissection) TAH/BSO 58954 37.13 All sites Omentectomy Debulking (radical dissection) Pelvic lymphadenectomy Limited para-aortic lymphadenectomy TAH/BSO 58956 22.80 All sites Omentectomy Debulking 58957 26.22 Recurrent gyn resection +/- omentectomy Debulking 58958 29.22 Recurrent gyn resection +/- omentectomy Pelvic lymphadenectomy Limited para-aortic lymphadenectomy Staging (second look) 58960 15.79 Specific for ovarian, tubal, or primary +/- omentectomy peritoneal malignancy Biopsy abd/pelvic Pelvic and limited para-aortic lymphadenectomy Ovarian/ Laparoscopic Peritoneal Second look with biopsy 49321 5.44 No codes for debulking: unlisted With nodes 38572 16.94 Staging 49320 5.14 22 modifier as appropriate 38572 16.94 3 Common Surgical Procedures Gyn/Oncology Malignancy Description Code wR VU Comments Vaginal Open Vaginectomy, partial 57106 7.50 Vaginectomy, partial 57107 24.56 Removal of paravaginal tissue (radical) Vaginectomy, partial 57109 28.40 Removal of paravaginal tissue (radical) Bilateral total pelvic lymphadenectomy Para-aortic lymph node sampling Vaginectomy, complete 57110 15.48 Vaginectomy, complete 57111 28.40 Removal of paravaginal tissue (radical) Vaginectomy, complete 57112 30.52 Removal of paravaginal tissue (radical) Bilateral total pelvic lymphadenectomy Para-aortic lymph node sampling Biopsy of vaginal mucosa, simple 57100 1.20 Biopsy of vaginal mucosa, extensive 57105 1.74 Requires sutures Includes cysts Destruction of lesion(s), simple 57061 1.30 Destruction of lesion(s), extensive 57065 2.66 4 Common Surgical Procedures Gyn/Oncology Maligna ncy Description Code wR VU Comments Vulvar Simple: removal of skin and superficial subcutaneous tissue Radical: removal of skin and deep subcutaneous tissue Partial: Removal of <80% vulvar area Complete: Removal of >80% vulvar area Vulva r Open Vulvectomy, simple, partial 56620 7.53 Vulvectomy, simple, complete 56625 9.68 Vulvectomy, radical, partial 56630 14.80 Vulvectomy, radical, partial 56631 18.99 Unilateral inguinofemoral lymphadenectomy Vulvectomy, radical, partia l 56632 21.86 Bilateral inguinofemoral lymphadenectomy Vulvectomy, radical, complete 56633 19.62 Vulvectomy, radical, complete 56634 20.66 Unilateral inguinofemoral lymphadenectomy Vulvectomy, radical, complete 56637 24.75 Bilateral inguinofemoral lymphadenectomy Vulvectomy, radical, complete 56640 24.78 Inguinofemoral lymphadenectomy Iliac lymphadenectomy Pelvic lymphadenectomy Biopsy vulva or perineum; 1 lesion 56605 1.10 Biopsy of each additional lesion vulva or +56606 0.55 Add on code. Use with 56605 perineum Excision benign lesion of genitalia 11420 - Varies Based on excised diameter. 11426 by Use if skin not excised. code Excision malignant lesion of genitalia 11620 - Varies Based on excised diameter. 11626 by Use if skin not excised. code Intermediate repair code genitalia 12041 - Varies Use in conjunction with 11420 -11426 12047 by and 11620-11626 if layered closure code required 5 Common Surgical Procedures Gyn/Oncology Malignancy Description Code wR VU Comments Bowel Open Procedures Partial Partial col ectomy with anastomosis 44140 22.59 Colectomy Partial colectomy 44141 29.91 Skin level cecostomy or colostomy Partial colectomy 44143 27.79 End colostomy and closure of distal segment (Hartmann type procedure) Partial colectomy 44144 29.91 Resection, with colostomy or ileostomy Creation of mucofistula Partial colectomy 44145 28.58 Coloproctostomy (low pelvic anastomosis) Partial colectomy 44146 35.30 Coloproctostomy (low pelvic anastomosis) Colostomy Partial colectomy 44147 33.69 Abdominal and Transanal approach Mobilization (take -down) of splenic +44139 2.23 Add on code. Use with 44140 -44147 flexure Colectomy, partial 44160 20.89 Removal of terminal ileum with ileocolostomy Total Colectomy, total 44150 30.18 Colectomy Ileostomy or ileoproctostomy Total colectomy 44151 34.92 Continent ileostomy Total colectomy 44155 34.42 Proctectomy Ileostomy Total colectomy 44156 37.42 Proctectomy Continent ileostomy Total colectomy 44157 35.70 Includes loop ileostomy, and rectal Proctectomy mucosectomy, when performed Ileoanal anastomosis, Total colectomy 44158 36.70 Includes loop ileostomy, and rectal Proctectomy mucosectomy, when performed Ileoanal anastomosis Creation of ileal reservoir (S or J) Enterectomy Small bowel resection 44120 20.82 Each additional resection and +44121 4.44 Add -on code. Use with 44120 anastomosis Small bowel resection 44125 20.03 Enterostomy 6 Common Surgical Procedures Gyn/Oncology Malignancy Description Code wR VU Comments Bowel Laparoscopic Procedures Laparoscopic enterectomy 44202 23.39 Single resection of small intestine Anastomosis Each additional small intestine resection +44203 4.44 Add -on code. Use with 44202 and anastomosis Laparoscopic partial colectomy Anastomosis 44204 26.42 Laparoscopic partial colectomy 44205 22.95 Removal of terminal ileum Ileocolostomy Laparoscopic partial colectomy 44206 29.79 End colostomy and closure of distal segment (Hartmann type procedure) Laparoscopic partial colectomy 44207 31.92 Coloproctostomy (low pelvic anastomosis) Laparoscopic partial colectomy 44208 33.99 Coloproctostomy (low pelvic anastomosis) Colostomy Laparoscopy mobilization (take -down) of +44213 3.50 Add -on code. Use with 44204 -44208 splenic flexure 7 Common Surgical Procedures Gyn/Oncology Malignancy Description Code wR VU Comments Other Open Procedures Exploratory laparotomy 49000 12.54 Includes biopsies if performed Excision or destruction, open, intra -abdominal 49203 20.13 Codes appropriate when primary organs tumors, cysts or endometriomas, 1 or more have been removed. peritoneal, mesenteric, or retroperitoneal primary If ovarian tumor, use appropriate ovarian or secondary tumors; largest tumor 5 cm diameter tumor or BSO code. or less Largest tumor 5.1 -10.0 cm diameter 49204 26.13 Largest tumor greater than 10.0 cm diameter 492 05 30.13 Appendectomy ; 44950 10.60 For indicated purpose at time of major +44955 1.53 Add -on code. Report in addition to procedure primary surgical
Recommended publications
  • FGM in Canada
    Compiled by Patricia Huston MD, MPH Scientific Communications International, Inc for the Federal Interdepartmental Working Group on FGM. Copies of this report are available from: Women's Health Bureau Health Canada [email protected] The Canadian Women's Health Network 203-419 Graham Avenue Winnipeg, Manitoba R3C 0M3 fax: (204)989-2355 The opinions expressed in this report are not necessarily those of the Government of Canada or any of the other organizations represented. Dedication This report is dedicated to all the women in the world who have undergone FGM and to all the people who are helping them live with and reverse this procedure. This report is part of the ongoing commitment of Canadians and the Government of Canada to stop this practice in Canada and to improve the health and well-being of affected women and their communities. Executive Summary Female genital mutilation (FGM), or the ritual excision of part or all of the external female genitalia, is an ancient cultural practice that occurs around the world today, especially in Africa. With recent immigration to Canada of peoples from Somalia, Ethiopia and Eritrea, Sudan and Nigeria, women who have undergone this practice are now increasingly living in Canada. It is firmly believed by the people who practise it, that FGM improves feminine hygiene, that it will help eliminate disease and it is thought to be the only way to preserve family honour, a girl's virginity and her marriageability. FGM has a number of important adverse health effects including risks of infection and excessive bleeding (often performed when a girl is pre-pubertal).
    [Show full text]
  • Core Curriculum for Surgical Technology Sixth Edition
    Core Curriculum for Surgical Technology Sixth Edition Core Curriculum 6.indd 1 11/17/10 11:51 PM TABLE OF CONTENTS I. Healthcare sciences A. Anatomy and physiology 7 B. Pharmacology and anesthesia 37 C. Medical terminology 49 D. Microbiology 63 E. Pathophysiology 71 II. Technological sciences A. Electricity 85 B. Information technology 86 C. Robotics 88 III. Patient care concepts A. Biopsychosocial needs of the patient 91 B. Death and dying 92 IV. Surgical technology A. Preoperative 1. Non-sterile a. Attire 97 b. Preoperative physical preparation of the patient 98 c. tneitaP noitacifitnedi 99 d. Transportation 100 e. Review of the chart 101 f. Surgical consent 102 g. refsnarT 104 h. Positioning 105 i. Urinary catheterization 106 j. Skin preparation 108 k. Equipment 110 l. Instrumentation 112 2. Sterile a. Asepsis and sterile technique 113 b. Hand hygiene and surgical scrub 115 c. Gowning and gloving 116 d. Surgical counts 117 e. Draping 118 B. Intraoperative: Sterile 1. Specimen care 119 2. Abdominal incisions 121 3. Hemostasis 122 4. Exposure 123 5. Catheters and drains 124 6. Wound closure 128 7. Surgical dressings 137 8. Wound healing 140 1 c. Light regulation d. Photoreceptors e. Macula lutea f. Fovea centralis g. Optic disc h. Brain pathways C. Ear 1. Anatomy a. External ear (1) Auricle (pinna) (2) Tragus b. Middle ear (1) Ossicles (a) Malleus (b) Incus (c) Stapes (2) Oval window (3) Round window (4) Mastoid sinus (5) Eustachian tube c. Internal ear (1) Labyrinth (2) Cochlea 2. Physiology of hearing a. Sound wave reception b. Bone conduction c.
    [Show full text]
  • Once in a Lifetime Procedures Code List 2019 Effective: 11/14/2010
    Policy Name: Once in a Lifetime Procedures Once in a Lifetime Procedures Code List 2019 Effective: 11/14/2010 Family Rhinectomy Code Description 30160 Rhinectomy; total Family Laryngectomy Code Description 31360 Laryngectomy; total, without radical neck dissection 31365 Laryngectomy; total, with radical neck dissection Family Pneumonectomy Code Description 32440 Removal of lung, pneumonectomy; Removal of lung, pneumonectomy; with resection of segment of trachea followed by 32442 broncho-tracheal anastomosis (sleeve pneumonectomy) 32445 Removal of lung, pneumonectomy; extrapleural Family Splenectomy Code Description 38100 Splenectomy; total (separate procedure) Splenectomy; total, en bloc for extensive disease, in conjunction with other procedure (List 38102 in addition to code for primary procedure) Family Glossectomy Code Description Glossectomy; complete or total, with or without tracheostomy, without radical neck 41140 dissection Glossectomy; complete or total, with or without tracheostomy, with unilateral radical neck 41145 dissection Family Uvulectomy Code Description 42140 Uvulectomy, excision of uvula Family Gastrectomy Code Description 43620 Gastrectomy, total; with esophagoenterostomy 43621 Gastrectomy, total; with Roux-en-Y reconstruction 43622 Gastrectomy, total; with formation of intestinal pouch, any type Family Colectomy Code Description 44150 Colectomy, total, abdominal, without proctectomy; with ileostomy or ileoproctostomy 44151 Colectomy, total, abdominal, without proctectomy; with continent ileostomy 44155 Colectomy,
    [Show full text]
  • GENDER DYSPHORIA TREATMENT Policy Number: 2016T0580A Effective Date: January 1, 2017
    UnitedHealthcare® Commercial Medical Policy GENDER DYSPHORIA TREATMENT Policy Number: 2016T0580A Effective Date: January 1, 2017 Table of Contents Page Related Commercial Policy INSTRUCTIONS FOR USE .......................................... 1 Blepharoplasty, Blepharoptosis and Brow Ptosis BENEFIT CONSIDERATIONS ...................................... 1 Repair COVERAGE RATIONALE ............................................. 2 Botulinum Toxin A and B DEFINITIONS .......................................................... 3 Cosmetic and Reconstructive Procedures APPLICABLE CODES ................................................. 4 DESCRIPTION OF SERVICES ...................................... 8 Gonadotropin Releasing Hormone Analogs CLINICAL EVIDENCE ................................................. 8 Panniculectomy and Body Contouring Procedures U.S. FOOD AND DRUG ADMINISTRATION ................... 11 Rhinoplasty and Other Nasal Surgeries CENTERS FOR MEDICARE AND MEDICAID SERVICES ... 11 Speech Language Pathology Services REFERENCES .......................................................... 11 POLICY HISTORY/REVISION INFORMATION ................ 12 Community Plan Policy Gender Dysphoria Treatment Related Optum Guideline Gender Dysphoria INSTRUCTIONS FOR USE This Medical Policy provides assistance in interpreting UnitedHealthcare benefit plans. When deciding coverage, the member specific benefit plan document must be referenced. The terms of the member specific benefit plan document [e.g., Certificate of Coverage (COC), Schedule of
    [Show full text]
  • April 2013, Volume 5, Issue 4
    VOLUME 5 MONTHLY ISSUE MEDICAL STAFF 4 NEWSLETTER ProgressNotes April TORRANCE MEMORIAL MEDICAL CENTER 2013 this issue CPOE P.1 Doctor’s Day P.2 MEC Approvals P.3-4 Medical Staff Calendar P.5 New Providers P.6 Roster Updates P.6 What is it? CPOE Select Rewards is a tiered program geared to reward pro- CPOE viders as they expand their use of CPOE (Computerized Provider Order Entry). Computerized How are providers enrolled in the CPOE Select Rewards Provider Order Program? Entry Select Enrollment is automatic as you or your group begins CPOE. Rewards Program How does it work? Providers qualify for monthly raffles based on meeting or exceed- ing CPOE percentage goals for their assigned tier. When will winners be announced? Winners will be announced the second Monday of every month, beginning in April. CPOE Monthly Raffle includes several prizes including an i-Pad mini. Individualized program details will be sent out to providers. Please call CPOE hotline at x2763 (xCPOE) if you have any questions. Doctor’s Day Thank you to all the physicians who attended the Doctor’s Day Celebration at Torrance Memorial on Wednesday, March 27th. The event was a success with many physicians attending to enjoy a great meal, music and prizes. Congratulations to Dr. Lauren Nguyen and Dr. James Flores, the two lucky winners of the iPad mini and the thirty physicians who also won gift cards to Nordstroms, California Pizza Kitchen, HealthLinks, Starbucks and iTunes. Torrance Memorial appreciates our physicians’ dedication and commitment to the health of our community. Medical Executive Committee Approvals The following items were presented and actions were approved at the March 12, 2013 Medical Executive Committee meeting: A.
    [Show full text]
  • Gender Dysphoria Treatment – Commercial Medical Policy
    UnitedHealthcare® Commercial Medical Policy Gender Dysphoria Treatment Policy Number: 2021T0580J Effective Date: April 1, 2021 Instructions for Use Table of Contents Page Related Commercial Policies Coverage Rationale ....................................................................... 1 • Blepharoplasty, Blepharoptosis and Brow Ptosis Documentation Requirements ...................................................... 3 Repair Definitions ...................................................................................... 4 • Botulinum Toxins A and B Applicable Codes .......................................................................... 5 • Cosmetic and Reconstructive Procedures Description of Services ................................................................. 9 • Gonadotropin Releasing Hormone Analogs Benefit Considerations .................................................................. 9 Clinical Evidence ......................................................................... 10 • Habilitative Services and Outpatient Rehabilitation U.S. Food and Drug Administration ........................................... 15 Therapy References ................................................................................... 15 • Panniculectomy and Body Contouring Procedures Policy History/Revision Information ........................................... 16 • Rhinoplasty and Other Nasal Surgeries Instructions for Use ..................................................................... 17 Community Plan Policy • Gender Dysphoria
    [Show full text]
  • Sexuality for the Woman with Cancer
    Sexuality for the Woman With Cancer Cancer, sex, and sexuality When you first learned you had cancer, you probably thought mostly of survival. But after a while other questions may have started coming up. You might be wondering “How ‘normal’ can my life be, even if the cancer is under control?” Or even “How will cancer affect my sex life?” It’s important to know that you can get help if you are having sexual problems after cancer treatment. There are many good treatments available. Sex and sexuality are important parts of everyday life. The difference between sex and sexuality is that sex is thought of as an activity – something you do with a partner. Sexuality is more about the way you feel about yourself as a woman, and is linked to intimacy or your need for caring, closeness, and touch. Feelings about sexuality affect our zest for living, our self-image, and our relationships with others. Yet patients and doctors often do not talk about the effects of cancer treatment on a woman’s sex life or how she can address problems she’s having. Why? A person may feel uneasy talking about sex with a professional like a doctor or even with a close sex partner. Many people feel awkward and exposed when talking about sex. This information is for all women who have or have had cancer – regardless of their sexual orientation. We cannot answer every question, but we’ll try to give you enough information to help you and your partner have open, honest talks about intimacy and sex.
    [Show full text]
  • Guidelines for the Diagnosis and Management of Vulval Carcinoma
    Guidelines for the Diagnosis and Management of Vulval Carcinoma May 2014 Contents Development of the document 4 Summary of consensus statements 5 1. Background 7 Objectives Methodology Definitions of excision 2. Screening, diagnosis and presentation 9 Screening Presentation National Institute for Health and Care Excellence (NICE) guidance Diagnosis Biopsies 3. Pathology 13 Microscopic Spread Staging Prognosis Histology Clinical information Ancillary studies 4. Treatment of primary disease 16 Surgery Reconstructive surgery Surgical management of nonsquamous vulval cancer Morbidity related to surgery 5. Radiotherapy 23 Primary treatment 2 6. Chemotherapy 25 Neoadjuvant chemotherapy for invasive squamous cell carcinoma Adjuvant chemotherapy for vulval cancer Chemotherapy for metastatic and recurrent vulval cancer Concomitant chemotherapy and radiotherapy Future developments 7. Treatment of recurrent disease 28 Recurrence rates and survival Groin recurrence Chemotherapy for relapsed disease 8. Follow-up 30 References 31 Appendix I 35 3 Development of the document This report is an updated version of that published by the Royal College of Obstetricians and Gynaecologists in January 2006. The following individuals have contributed to previous RCOG editions of this guideline: Professor DM Luesley FRCOG Mr DPJ Barton MRCOG Mr M Bishop FRCS Eng (Consultant Urologist), City Hospital, Nottingham Dr P Blake FRCR (Consultant Radiotherapist) Dr CH Buckley FRCPath (Honorary Consultant Histopathologist) Dr JA Davis FRCOG Mr M Ledwick RGN (Cancer Information
    [Show full text]
  • SJH Procedures
    SJH Procedures - Gynecology and Gynecology Oncology Services New Name Old Name CPT Code Service ABLATION, LESION, CERVIX AND VULVA, USING CO2 LASER LASER VAPORIZATION CERVIX/VULVA W CO2 LASER 56501 Destruction of lesion(s), vulva; simple (eg, laser surgery, Gynecology electrosurgery, cryosurgery, chemosurgery) 56515 Destruction of lesion(s), vulva; extensive (eg, laser surgery, Gynecology electrosurgery, cryosurgery, chemosurgery) 57513 Cautery of cervix; laser ablation Gynecology BIOPSY OR EXCISION, LESION, FACE AND NECK EXCISION/BIOPSY (MASS/LESION/LIPOMA/CYST) FACE/NECK General, Gynecology, Plastics, ENT, Maxillofacial BIOPSY OR EXCISION, LESION, FACE AND NECK, 2 OR MORE EXCISE/BIOPSY (MASS/LESION/LIPOMA/CYST) MULTIPLE FACE/NECK 11102 Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); General, Gynecology, single lesion Aesthetics, Urology, Maxillofacial, ENT, Thoracic, Vascular, Cardiovascular, Plastics, Orthopedics 11103 Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); General, Gynecology, each separate/additional lesion (list separately in addition to Aesthetics, Urology, code for primary procedure) Maxillofacial, ENT, Thoracic, Vascular, Cardiovascular, Plastics, Orthopedics 11104 Punch biopsy of skin (including simple closure, when General, Gynecology, performed); single lesion Aesthetics, Urology, Maxillofacial, ENT, Thoracic, Vascular, Cardiovascular, Plastics, Orthopedics 11105 Punch biopsy of skin (including simple closure, when General, Gynecology, performed); each separate/additional lesion
    [Show full text]
  • Icd-9-Cm (2010)
    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
    [Show full text]
  • Gender Reassignment Surgery Model Ncd
    GENDER REASSIGNMENT SURGERY MODEL NCD I. Indications, Limitations of Coverage and/or Medical Necessity 1 II. Documentation Requirements 4 III. Providers of Gender Reassignment Surgery 5 IV. Common CPT Codes 5 V. ICD-9 and ICD-10 Codes 8 VI. References 9 Written by Transgender Medicine Model NCD Working Group. Contact: Anand Kalra, Transgender Law Center ([email protected]). Gender Reassignment Surgery Model NCD | 1 I. Indications, Limitations of Coverage and/or Medical Necessity The purpose of this National Coverage Determination is to implement the U.S. Department of Health and Human Services Departmental Appeals Board’s 2014 decision overturning NCD 140.3 (Transsexual Surgery). The U.S. Department of Health and Human Services Departmental Appeals Board (“DAB”) considered categories of evidence as outlined in the Medicare Integrity Program Manual § 13.7.1 when it determined that the previously extant prohibition on “transsexual surgery” in NCD 140.3 was unreasonable.1 Implementing a policy to provide access to Gender Reassignment Surgery is centered in improving population health outcomes among transgender Medicare beneficiaries. The Medicare Integrity Program Manual § 13.7.1 provides that NCDs should be based on published authoritative evidence and general acceptance by the medical community. Summarized, this means treatments should follow: Evidence-based best practice derived from definitive studies such as meta-analyses, randomized clinical trials, or clinical evidence Best practice as accepted by the medical community, as supported by sound medical evidence based on: o Scientific data or research studies published in peer-reviewed medical journals; o Consensus of expert medical opinion (i.e., recognized authorities in the field); or o Medical opinion derived from consultations with medical associations or other health care experts.
    [Show full text]
  • Outpatient Surgical Procedures – Site of Service: CPT/HCPCS Codes
    UnitedHealthcare® Commercial Policy Appendix: Applicable Code List Outpatient Surgical Procedures – Site of Service: CPT/HCPCS Codes This list of codes applies to the Utilization Review Guideline titled Effective Date: August 1, 2021 Outpatient Surgical Procedures – Site of Service. Applicable Codes The following list(s) of procedure and/or diagnosis codes is provided for reference purposes only and may not be all inclusive. The listing of a code does not imply that the service described by the code is a covered or non-covered health service. Benefit coverage for health services is determined by the member specific benefit plan document and applicable laws that may require coverage for a specific service. The inclusion of a code does not imply any right to reimbursement or guarantee claim payment. Other Policies and Guidelines may apply. This list contains CPT/HCPCS codes for the following: • Auditory System • Female Genital System • Musculoskeletal System • Cardiovascular System • Hemic and Lymphatic Systems • Nervous System • Digestive System • Integumentary System • Respiratory System • Eye/Ocular Adnexa System • Male Genital System • Urinary System CPT Code Description Auditory System 69100 Biopsy external ear 69110 Excision external ear; partial, simple repair 69140 Excision exostosis(es), external auditory canal 69145 Excision soft tissue lesion, external auditory canal 69205 Removal foreign body from external auditory canal; with general anesthesia 69222 Debridement, mastoidectomy cavity, complex (e.g., with anesthesia or more
    [Show full text]